HFCL share price gains 10.7 per cent, hitting a 52-week high at ₹118.76 per share on posting strong Q4 results
Meesho is newly rated 'Overweight' at JPMorgan on ad monetisation, NMV growth
Cemindia Projects hits 20 per cent upper circuit after posting strong q4 results; PAT up 113 per cent YoY
MOIL shares slipped 5.5 per cent on Thursday on posting 20 per cent YoY fall in Q4 net profit; details here
Navin Fluorine shares gained 7 per cent post Q4 results but pared gains later; analysts bullish on growth outlook
Bajaj Finance share price rises over 4% after strong Q4 results; profit jumps 22 percent YoY, brokerages hike target price
While that may be the case for some, investing outside of the large-cap universe, or rather companies that haven't hit maturity, is more guided by intuition or feeling rather than by calculations
Stocks to buy: Ajit Mishra of Religare Broking recommends buying Airtel, PowerGrid and one other stock; here's why
The buying on the counter came after the company launched RAI (Reliability & Assurance Intelligence) - an AI-native QA automation agent, and also released its Q4FY26 results
In Q4, Rallis India's net loss declined to ₹15 crore, as compared to a net loss of ₹32 crore a year ago
In Q4, Jindal Saw reported a 52.1 per cent decline in net profit at ₹139.43 crore, as compared to ₹291.28 crore a year ago
Piramal Finance's net profit surged 390 per cent Y-o-Y to ₹502 crore in Q4FY26 from ₹102 crore a year ago, and rose 25 per cent sequentially
SBI Card reported a 14 per cent rise in profit to ₹609 crore for the fourth quarter ended March 2026, as compared to ₹534 crore a year ago.
Stocks to buy today: Shrikant Chouhan of Kotak Securities has suggested buying DCB Bank and Vedanta shares; here's why
Kirloskar Pneumatic Company posted a consolidated net profit of ₹143.8 crore for Q4, as compared to ₹80.3 crore a year ago, up 79 per cent
The buying on the counter came after the company entered into a technical collaboration agreement and supply agreement with China's Nanjing Haohang Technology Co
In Q4, Tanla Platforms reported consolidated net profit at ₹134.32 crore, as compared to ₹117.33 crore year-on-year (Y-o-Y), up 14.6 per cent.
Among others, Sun Pharma was the top gainer up over 7 per cent, followed by Gland Pharma, Alkem Laboratories, Zydus Lifesciences and Wockhardt up over 2 per cent
IndusInd Bank posted a net profit of ₹594.17 crore for Q4, as compared to a net loss of ₹288.71 crore a year ago.
M&M Finance posted a 106 per cent year-on-year (Y-o-Y) spike in net profit to ₹940 crore for Q4, as compared to ₹456 crore a year ago